TRACER accelerates clinical decision making by imaging drug binding in humans. TRACER specializes in clinical fluorescence optical and nuclear imaging and by using the FDA approved microdosing study design. It provides the fastest in-human accurate imaging data on whether the tested compound reaches the target tissue, making clinical trials more cost efficient and reach the market faster.